Angelique Hoelzemer
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Malignancy-Associated Hemophagocytic Lymphohistiocytosis: Clinical Characteristics, Treatment Patterns, and Survival Outcomes in a Tertiary Care Center Cohort.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 05, 2026
Acid sphingomyelinase is an age-dependent host cell factor for adenovirus entry and a pharmacological target for synergistic combination therapy with brincidofovir.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 10, 2026
A transatlantic joint lab model for interdisciplinary research.
Journal: Nature microbiology
Published: September 22, 2025
A dual compartment peripheral blood signature of soluble and membrane-bound immune checkpoints predicts outcome in lymphoma patients.
Journal: Oncoimmunology
Published: August 28, 2025
Harnessing innate immunity: natural killer cells and innate immune responses in reservoir clearance.
Harnessing innate immunity: natural killer cells and innate immune responses in reservoir clearance.
Journal: Current opinion in HIV and AIDS
Published: August 20, 2025
Host-virus determinants of Ebola virus persistence in a human cerebral organoid model.
Journal: Nature microbiology
Published: June 16, 2025
Synergistic antiviral activity against human adenovirus through combination of itraconazole and brincidofovir.
Journal: British journal of pharmacology
Published: April 28, 2025
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation.
Journal: Nature
Published: November 28, 2024
Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses.
Journal: Cell
Published: July 25, 2023
Targeted small molecule inhibitors blocking the cytolytic effects of pneumolysin and homologous toxins.
Journal: Nature communications
Published: July 14, 2023
Last Updated: 09/26/2026